CervoMed Inc.
NASDAQCRVO heads into Tuesday's Q1 earnings call with the stock down 13% on the month, a just-released EPS miss already on the tape, and short sellers quietly adding exposure for the past six weeks. The catalyst for Friday's 8.5% sell-off was an earnings miss filed after Thursday's close. Q1 EPS came in at -$0.86, missing the consensus estimate of -$0.78. The stock closed at $3.44 and is…
Snapshot as of 30 Jun 2026
CRVO heads into Tuesday's Q1 earnings call with the stock down 13% on the month, a just-released EPS miss already on the tape, and short sellers quietly adding exposure for the past six weeks. The catalyst for Friday's…
CRVO heads into its May 19 Q1 earnings with the stock trading near its weakest level in months and bears quietly building positions. The stock has fallen 15% over the past month to $3.44, including an 8.5% drop on…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CRVO — free to start on ORTEX.
Sign up for free →Open CRVO on ORTEX